1. From the Endothelial Cell Gene Expression Group, Vascular Disease Unit, Glaxo-Wellcome Medicines Research Centre, Stevenage (P.H., M.C.D., V.L., B.W., J.-L.S., C.C., M.B.), and the Haemostasis Research Group, MRC Clinical Sciences Centre, London (J.H.M.), UK; the Department of Immunology, The Scripps Research Institute, La Jolla, California (N.M.); and the Department of Engineering, University of Aberdeen, Scotland (J.M.R., D.G.G.).